Pembrolizumab Biosimilar - Research Grade

Human

PD-1

1.0 - 5.0 mg/ml

IgG4 kappa

Humanized

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.

Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Detects human PD-1. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Pembrolizumab.

Blue ice

Programmed cell death protein 1 (PD-1) is an inhibitory T-cell checkpoint receptor at the centre of cancer immunotherapy research. This research-grade anti-human PD-1 recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of pembrolizumab, built around the PD-1 target as an IgG4-kappa for research use only. Produced to in vivo standards as an ultra-pure, low-endotoxin preparation, it is supplied in scalable milligram to gram quantities for high-throughput and bulk laboratories. It serves as a dependable control and active reagent across preclinical applications, including checkpoint-blockade assays, in vitro T-cell screening, and in vivo tumour immunology models.

Programmed cell death protein 1, Pdcd1, CD279

Q15116

ICH3001-100ml ICH3002-100ml ICH3003-100ml

https://www.imgt.org/mAb-DB/